Related by context. All words. (Click for frequent words.) 88 Staphylococcus aureus Polysaccharide Conjugate 74 Civacir 73 highly purified pasteurized 72 HEPLISAV TM 72 Nicotine Conjugate Vaccine 71 FOLOTYN ® 70 oncolytic virus therapies 70 JOULFERON 70 DosePro TM 70 lucinactant 70 Receives Orphan Drug Designation 70 Immunotherapeutic 70 Initiates Phase II 69 Xcytrin R 69 StaphVAX 69 nanofiltered plasma derived 69 Completes Patient Enrollment 69 Allovectin 7 r 69 Phase IIb Trial 69 Initiates Clinical 69 candidates Azedra 69 Initiates Enrollment 69 investigational hepatitis B 69 PANVAC VF 69 Files IND 69 VIVITROL ® 69 Rhucin ® recombinant 69 Personalized Immunotherapy 69 oral prodrug 68 MT#/MEDI-# 68 MOVIPREP R 68 recombinant biopharmaceutical 68 Crofelemer budesonide foam 68 NDA Submission 68 molecular imaging radiopharmaceutical 68 Japanese Encephalitis Vaccine 68 GVAX ® 68 ALN PCS 68 Zemiva TM 68 Pivotal Phase III 68 Evoltra ® 68 Aganocide 68 acyclovir Lauriad R 68 Combination REOLYSIN R 68 Files Investigational 68 molecular therapeutics immunotherapies 68 TRANSDUR ® 68 PREOS R 68 Initiate Clinical Trial 68 HuMax TAC 68 Phase III Clinical Trial 68 ASE SVA 67 Therapeutic Competitors Companies 67 Dalbavancin 67 Onalta 67 RNAi Therapeutic 67 candidate REP# 67 NicVAX TM 67 Adjuvanted 67 PROVENGE ® 67 human C1 inhibitor 67 Vitrasert R 67 Achieves Primary Endpoint 67 TRANSDUR ™ 67 Cinryze ™ 67 Patient Enrollment 67 miconazole Lauriad R 67 Vaccine Adjuvant 67 methylnaltrexone bromide 67 Meets Primary Endpoint 67 Omigard 67 Phase 2b Clinical Trial 67 ZADAXIN ® 67 Solazed TM 67 brand ciclesonide HFA 67 SinuNase TM 67 Nasdaq PGNX today 67 Receives Approvable Letter 67 liver resection surgeries 67 Intercell vaccine 67 BiovaxID TM 67 MKC# MT 67 Alnylam #x# 67 ATryn R 67 Tezampanel 67 Submits Biologics License Application 67 Rhucin R 67 GTC recombinant human 67 TransVax TM 67 IV APAP 67 Rotarix ® 67 ELADUR ™ 67 Staphylococcus aureus Immune Globulin 67 motexafin gadolinium Injection 67 Application MAA 66 Kuvan TM sapropterin 66 ALVESCO R 66 R Nicotine Conjugate 66 Marketing Authorization Application 66 PentaStaph 66 Receives Positive Opinion 66 ZALBIN 66 submitted Biologics License 66 Initiates Phase III 66 Iluvien ® 66 Submits Supplemental 66 RECOTHROM ® 66 AMITIZA ® 66 Oral Calcitonin 66 Polymer Microspheres 66 tiapamil 66 candidates Azedra TM 66 gastro intestinal inflammation 66 Omigard TM 66 FDA Accepts 66 ELADUR TM 66 Icatibant 66 SNT MC# 66 Begins Dosing 66 Submits NDA 66 Prestara TM 66 Cetrorelix 66 include PLX IBD 66 Cleviprex TM clevidipine 66 Submits IND 66 PROSTASCINT R 66 KRYSTEXXA TM pegloticase 66 Application BLA 66 Panzem R 66 Maribavir 66 NOVAVAX 66 Intravenous Human 66 Protexia ® 66 pralatrexate injection folate analogue 66 recombinant subunit vaccine 66 SPRYCEL ® 66 ALTROPANE R 66 include Healive 66 Pafuramidine 66 Nasdaq NABI 66 anti botulism antibody 66 Nasal Powder 66 IMA# 66 Pivotal Trial 66 Expanded Indication 66 Surfaxin LS 66 Stimuvax R 66 Marketing Authorisation Application 66 delivers fluocinolone acetonide FA 66 equine osteoarthritis marketed 66 Valortim TM 66 Biologic License Application BLA 66 Imvamune 66 Initiates Clinical Trial 66 Kosan dependence 66 acetonide FA 66 Prodarsan R 66 GTC recombinant form 66 Phase III Pivotal 66 Vaccine Candidate 66 Initiates Clinical Trials 66 DPX Survivac 66 IND Filing 66 aldehyde dehydrogenase ALDH2 deficiency 66 Submits Response 66 Earns Milestone Payment 66 POSIDUR TM ELADUR TM 66 ZEGERID Capsules 65 PNP inhibitor 65 Mylan Receives Approval 65 BARACLUDE R 65 AzaSite TM 65 Presents Preclinical Data 65 PRNewswire FirstCall Pharmacopeia 65 Inhibitor Human 65 GATTEX TM 65 Neutrolin ® 65 Dyloject TM 65 Oracea TM 65 Wafer polifeprosan 65 Veronate 65 Fodosine 65 Phase III Trial 65 Genaera Corporation 65 QNEXA ® 65 supplemental Biologics License Application 65 Kuvan R 65 FACTIVE R gemifloxacin 65 Acetavance TM intravenous acetaminophen 65 Angiox ® 65 TOCOSOL Camptothecin 65 HEPLISAV ™ 65 successfully commercialize Iluvien 65 Somatuline Depot 65 Phase 2a clinical trials 65 MyVax R 65 tivozanib AV 65 Pandemic Influenza Vaccine 65 PLK1 SNALP 65 Inc. www.micromet inc.com 65 initiated Phase Ib 65 CD# CEA 65 GLOBE NEWSWIRE Cyclacel Pharmaceuticals 65 PDX pralatrexate 65 AAG geldanamycin analog 65 Demonstrates Significant 65 Fast Track Status 65 Phase 2b Trial 65 STELARA TM 65 REMOXY R 65 ATryn ® 65 Phase #b/#a clinical 65 Severe Sepsis 65 AdVac ® 65 TELINTRA R 65 FDA APPROVES 65 candidate NGX 65 Hepatitis C Virus HCV 65 Entereg TM 65 forodesine 65 orBec ® oral beclomethasone 65 SinuNase ™ 65 ALN TTR 65 Presents Positive 65 Receives Milestone Payment 65 G#DT 65 Phase 1b Clinical Trial 65 Receives Orphan Drug 65 Diamyd ® 65 Japanese Encephalitis vaccine 65 Drug Candidate 65 ESTRASORB R 65 RNAi Therapeutics 65 Allovectin 7 65 Nabi HB R 65 rxRNA 65 Anturol ® 65 Chimigen TM 65 IV acetaminophen 65 overactive bladder AA# 65 Trodusquemine MSI 65 CERVARIX R 65 SUMAVEL 65 Pirfenidone 65 HuCAL GOLD R 65 VISICOL R 65 Unigene nasal calcitonin 65 Pentacel R 65 Elagolix 65 candidate AQ4N 65 dihydrochloride Phase 3 65 www.ucb group.com 65 Acetavance TM 65 Unit Dose Budesonide 65 RiVax 65 Factor Xa Inhibitor 65 mesylate tablets 65 Granted Orphan Drug 65 miconazole MBT 65 kidney urologic 65 GVAX R 65 platinum chemotherapeutic 65 JZP 64 candidate TNFerade biologic 64 Psoriasis Drug 64 PRN FDA Approves 64 SEBIVO 64 Presents Preclinical 64 anti infective treatments 64 % uracil topical 64 Shigamabs ® 64 BENLYSTA ® 64 Influenza Virus Vaccine 64 candidate XP# 64 Loramyc R 64 Friedreich Ataxia FRDA 64 Cintredekin Besudotox 64 BLA filing 64 Hiberix 64 ATG Fresenius S 64 Novartis VIRT X 64 Rotarix R 64 Single Dose 64 Advanced Melanoma 64 TELINTRA 64 PDE4 inhibitor 64 ALVESCO ® 64 Nasdaq VRTX today 64 anthrax monoclonal antibody 64 Vaccine Protects Against 64 Biologics License Application 64 ILUVIEN ® 64 Aryplase 64 NASDAQ PGNX 64 investigational pharmacologically unique 64 Marketing Authorization Application MAA 64 Hsp# Inhibitor 64 Regeneron Pharma 64 Uvidem 64 Phase 2a Clinical Trial 64 CRMD# 64 SYCREST 64 XL# anticancer compounds 64 RECOTHROM R 64 SIX RO ROG 64 Announces Poster Presentations 64 Vascular Wrap TM 64 please visit http:/www.vandapharma.com 64 IXIARO ® 64 intravenous acetaminophen 64 OTCBB HXBM developer 64 Successfully Completes Phase 64 Inhalation Solution 64 JAK2 Inhibitor 64 NUEDEXTA ™ 64 NASDAQ AVNR 64 Asentar TM 64 Veronate R 64 supplemental biologics 64 Nasdaq VNDA 64 virus HCV protease inhibitor 64 EVIZON TM squalamine lactate 64 Aloxi ® 64 Ceflatonin R 64 commercializing anti infective 64 Therapeutic Vaccine 64 REG1 Anticoagulation System 64 Perflubutane Polymer Microspheres 64 investigational humanized monoclonal antibody 64 Patient Enrolment 64 SPL# Gel vaginal microbicide 64 ® bortezomib 64 Demonstrates Positive 64 Peginterferon alfa 2b 64 submitted Marketing Authorization 64 Nasdaq HALO 64 Silenor ® doxepin 64 LibiGel ® 64 Milestone Payment 64 Completes Enrollment 64 targeting Inflammatory Bowel 64 Taiho Pharmaceutical 64 Raptiva R 64 EVIZON TM 64 Teikoku Pharma USA 64 Anidulafungin 64 refractory chronic lymphocytic 64 Femring ® 64 ONCONASE R 64 MAA submission 64 Allovectin 7 R 64 Therapeutic Competitors companiesandmarkets.com adEgemonye 64 Generx TM 64 Fortical R 64 Ceplene TM 64 Initiate Phase III 64 topically applied SEPA 64 include Altastaph TM 64 BYETTA ® 64 Inhalation Aerosol 64 ALN HPN 64 Mepact 64 Eraxis 64 Prednisporin TM 64 treat dysmenorrhea 64 Novel Antibiotic 64 CB2 selective receptor agonist 64 NASDAQ BTRX pharmaceutical 64 Exherin TM 64 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 64 Campath ® 64 Announces Tentative Approval 64 Xolegel 64 Adagen ® 64 t2cure GmbH 64 Sanofi Pasteur Fluzone 64 oral proteasome inhibitor 64 Generic Version 64 First Patient Dosed 64 Onalta ™ 64 targeted radiotherapeutic 64 RELISTOR ® 64 mocetinostat MGCD# 64 PRNewswire FirstCall Pharmasset 64 interferon gamma 1b 64 Novel Oral 64 Fx #A 64 SHP.L 64 P#X# antagonist 64 subcutaneous formulation 64 PREVENAR 64 volociximab 64 Juvaris BioTherapeutics 64 Marketing Authorisation Application MAA 64 antigen rPA anthrax 64 CCR9 antagonist 64 Zorbtive TM 64 SUPPRELIN R LA 64 fully liquid pentavalent 64 Insegia 64 4SC AG ISIN DE# 63 ZEVALIN ® 63 Serostim ® 63 Nabi HB Intravenous 63 7 valent Conjugate 63 include Phenoptin TM 63 Preotact R 63 MCSP respectively 63 Ecallantide 63 HepeX B 63 Myrexis Inc. 63 Pivotal Phase 63 Through Glycoscience R 63 Phase IIb Clinical Trial 63 vinorelbine emulsion 63 Alvine Pharmaceuticals 63 Vitrasert ® 63 personalized cellular immunotherapy 63 By JAMAAL ABDUL 63 vosaroxin 63 mertansine 63 Soliris eculizumab 63 HuCAL PLATINUM ® CysDisplay 63 Qutenza TM 63 Idera Pharmaceuticals 63 Aloxi R 63 novel therapeutic antibodies 63 NASDAQ INGN 63 Entereg R 63 Mycamine 63 Merck Suspends Lobbying 63 NYSE Amex PBTH 63 Nasdaq DVAX 63 trastuzumab DM1 T DM1 63 markets HP Acthar 63 candidate MyVax 63 hepatitis B measles mumps 63 oral methylnaltrexone 63 diagnostic radiopharmaceutical 63 treat lupus renal 63 TRANSDUR Bupivacaine 63 MyVax ® 63 Piperacillin 63 Romiplostim 63 albiglutide 63 ketolide antibiotic 63 Reports Preclinical Data 63 therapeutic monoclonal antibodies 63 candidate Zenvia 63 Announce License Agreement 63 recombinant hepatitis B 63 PhosLo R 63 Lenocta TM 63 LymphoStat B belimumab 63 Vaccine Recombinant 63 phase IIb clinical 63 telomerase therapeutic 63 Myocet 63 Levoleucovorin 63 Aradigm Corporation 63 RANK Ligand inhibitor 63 LymphoStat B TM 63 Augment TM 63 histamine dihydrochloride 63 topical anti infective 63 NOVARTIS 63 Clinical Trial Results 63 sapacitabine CYC# 63 Safinamide 63 Xyfid TM 63 initiated Phase 1b 63 Tyzeka Sebivo 63 BUPHENYL R 63 Azilect ® 63 investigational monoclonal antibody 63 Haemophilus b Conjugate 63 HuMax HepC TM 63 investigational pan BCR 63 Pegloticase 63 NYSE Amex PTN 63 Receives Fast Track 63 equine osteoarthritis 63 Disease IBD 63 Tigecycline 63 Complicated Skin 63 CysDisplay R 63 Tibotec Therapeutics division 63 OTCBB INSV 63 GlaxoSmithKline Biologicals SA 63 AdVac R 63 HYVISC ® treatment 63 Initiates Phase 2b 63 dose intramuscular 63 Tuberculosis Vaccine 63 antibody MAb 63 Skin Cholesterol Test 63 ibuprofen Injection 63 faropenem medoxomil 63 purified inactivated vaccine 63 pharmacogenomic translational research 63 TRACON Pharmaceuticals 63 mitogen activated ERK kinase 63 SynCon ™ DNA 63 VALSTAR 63 rALLy clinical trial 63 vapreotide acetate 63 Prostate Cancer Vaccine 63 Pivotal Study 63 AVP #D# 63 tramiprosate Alzhemed TM 63 SCHWARZ PHARMA 63 PRT# 63 Opterone R 63 Exherin 63 Empatic TM 63 Recombinant Human 63 Initiate Phase 63 Archexin 63 rPA anthrax vaccine 63 NEBIDO VANTAS SUPPRELIN LA 63 R bortezomib 63 BioGlue ® 63 Telik logo TELINTRA 63 ABILIFY R 63 Humenza 63 Eligard ® 63 ROTATEQ 63 PRAECIS PHARMACEUTICALS INCORPORATED 63 BENLYSTA TM 63 FluINsure 63 SparVax ™ 63 commercializing Loramyc ® 63 FUSILEV ® 63 Nasdaq CRXL 63 albinterferon alfa 2b 63 Interferon beta 1a 63 SinoFresh TM 63 Hematide TM 63 intranasal formulation 63 Alfacell proprietary ribonuclease 63 Hemorrhagic Stroke caused 63 HepaGam B 63 Barrier Therapeutics Inc. 63 UCB www.ucb group.com 63 Nasdaq DYAX 63 Glufosfamide 63 TRIOLEX HE# APOPTONE HE# 63 sapropterin dihydrochloride Tablets 63 oral salmon calcitonin 63 diarrhea fatigue asthenia 63 proprietary intranasal insulin 63 THR beta agonist 63 Panflu 63 visit www.targanta.com 63 Tarsa Therapeutics 63 MEK Inhibitor 63 NPC 1C 63 R Saizen R 63 Oral Insulin 63 IND Application 63 NEBIDO R 63 product BioThrax ® 63 Orphan Status 63 sorafenib tablets 63 Nasdaq HALO biopharmaceutical 63 ionotropic glutamate receptor antagonists 63 David W. Gryska 63 Announcement acc 63 Inc. Nasdaq VNDA 63 Initiates Dosing 63 Receives Marketing Authorization 63 label Lipofen R 63 CYCLOSET ® 63 BioGlue R 63 H#N# VLP vaccine 63 candidates bavituximab 63 nasal calcitonin product 63 Catena ® 63 Nexavar sorafenib 63 ORENCIA R 63 Actimmune ® 63 Pivotal Clinical Trial 63 OTCBB PYTO 63 OvaRex R 63 NASDAQ CRXL 63 Leukine ® 63 Presents Positive Preclinical 63 Phase Ib IIa 63 PGL# 63 EV# vaccine 63 PREVNAR 63 commercialize ZYFLO CR 63 Voraxaze 63 HQK 63 RapidResponse TM DNA 63 vaginally administered lidocaine 63 Inc. NASDAQ AEZS 63 Roche OTC RHHBY 63 PDUFA Date 63 Dexilant 63 Alinia 63 induced macular edema 63 Vion Pharmaceuticals 63 Bendamustine 62 protein tyrosine phosphatase 1B 62 cathepsin K inhibitor 62 Cerus Corporation 62 Modified Vaccinia Ankara MVA 62 Vicriviroc 62 CholeraGarde R 62 AstraZeneca AZN.L 行情 62 IMVAMUNE TM 62 chemotherapy induced neutropenia 62 OTCBB IMNR 62 Phase III Trials 62 miconazole Lauriad ® 62 Golimumab 62 ApoB SNALP 62 Gentamicin Surgical Implant 62 Thrombin topical Recombinant 62 Ustekinumab 62 Phase III Clinical Trials 62 Pruvel TM 62 Amigal TM 62 Vaxfectin 62 R Influenza Virus 62 Milestone Payments 62 Loramyc 62 Rotavirus Vaccine 62 Romidepsin 62 Zemiva ™ 62 ASONEP TM 62 BiTE R 62 Release Capsules 62 AMEX ONI 62 CMV vaccine 62 Zaleplon Capsules 62 pentadentate logo R 62 Receives Complete Response 62 Onalta TM 62 Cardium Therapeutics TM 62 INTEGRILIN R eptifibatide Injection 62 BioSante Pharmaceuticals Announces 62 Trofex TM 62 Fresenius Biotech 62 CERVARIX 62 tramiprosate ALZHEMED TM 62 5 HT3 antagonist 62 Zingo TM 62 Proquin XR 62 vaccine Synflorix 62 Somatuline R Autogel R 62 Albugon 62 liposomal formulation 62 MOZOBIL 62 Filgrastim 62 Sagent Pharmaceuticals Announces 62 aerosolized AAT 62 CINTREDEKIN BESUDOTOX 62 lintuzumab SGN 62 REBETOL combination therapy 62 Cloretazine ® 62 ABLYNX 62 leading oral taxane 62 product platforms AZX# 62 Aflibercept 62 Chemokine Therapeutics 62 Tesetaxel 62 First Patient Enrolled 62 platforms GVAX 62 Protexia R 62 Nitazoxanide 62 delivery polymer matrix 62 OMNARIS Nasal Spray 62 dependent kinase inhibitor 62 CRM# Protein 62 Begins Shipment 62 Menjugate 62 Cerebril TM 62 Nasdaq CYCC 62 recombinant protective 62 Cethromycin 62 ProtAffin 62 TBC# 62 Phase 2a Trial 62 sapropterin dihydrochloride 62 novel antibody therapeutics 62 Supplemental Biologics License Application 62 R bendamustine hydrochloride 62 Aerosurf 62 Alzhemed TM 62 non porcine pancreatic 62 TransVax tm 62 CCR5 mAb 62 THALOMID 62 PAION AG ISIN 62 Nasdaq TARG 62 Gel repository corticotropin injection 62 oxybutynin ATD TM 62 IMPDH inhibitor 62 world safest multivalent 62 NasdaqGM NTEC today 62 GTC NASDAQ GTCB 62 AVI BioPharma Announces 62 OSMOPREP 62 pneumococcal conjugated vaccine 62 dacetuzumab SGN 62 Maxy G# 62 CTAP# Capsules 62 BioWa 62 Firdapse 62 vidofludimus 62 Keppra ® XR 62 Alferon N 62 candidate deforolimus 62 YONDELIS 62 Nanobody ® 62 Agonist MABA program 62 Biologics License Application BLA 62 CEQ# 62 rPA Anthrax Vaccine 62 Altastaph 62 LEVADEX TM 62 Orphan Drug Status 62 FavId 62 Dasatinib 62 Trial Evaluating 62 recurrent metastatic ovarian cancer 62 include Alferon N 62 rilonacept 62 Nasdaq XTLB 62 TNF Tumor Necrosis Factor 62 refractory gout 62 Zemiva TM Trofex TM 62 Fibrillex TM 62 Hematide ™ peginesatide 62 novel MetAP 2 62 HCl PEPCID ® famotidine 62 product candidate Lpathomab 62 SynCon 62 candidate Zemiva TM 62 r hGH 62 R sorafenib tablets 62 First Patient Treated 62 Vidaza R 62 OTC BB PVCT 62 OMP designation 62 Onco TCS 62 faropenem 62 including eniluracil ADH 62 Cervarix cervical cancer 62 Receives CE Marking 62 Fludara ® 62 PRNewswire FirstCall Labopharm 62 Bazedoxifene 62 Hybridon 62 Fortigel 62 TOCOSOL Paclitaxel 62 IL# PE#QQR 62 Receive Milestone Payment 62 Adjuvant Treatment 62 Combination Therapy 62 Liberte TM 62 JV SpeBio 62 ALN TTR# 62 inflammatory autoimmune diseases 62 TAXUS Element Paclitaxel Eluting 62 Pancreas Cancer Vaccine 62 L BLP# 62 Ovitrelle R Serostim 62 SAR# [004] 62 Adenosine Therapeutics 62 LUCASSIN 62 Lovaza TM 62 Somatuline R Depot 62 Aurexis 62 Rhucin ® 62 Telbivudine 62 Tykerb lapatinib 62 levocetirizine 62 Oral Fingolimod 62 VivaGel ™ 62 Plaque Psoriasis 62 BioThrax Anthrax Vaccine Adsorbed 62 Soliris TM eculizumab 62 ANTEGREN 62 Enhanze 62 RhuDex ® 62 Factor VIIa 62 Intravenous CP 62 non nucleoside HCV 62 ROTATEQ ® 62 Regenerative Cells 62 Positive Opinion 62 doxercalciferol 62 lexidronam injection 62 formerly LymphoStat B 62 rasagiline tablets 62 Orphan Drug designations 62 Solazed ™ 62 Corixa Corporation 62 Liprotamase 62 Vivecon 62 commercializing therapeutic 62 Xcellerex FlexFactory 62 NasdaqGM SPPI 62 Toxoid 62 Besivance 62 CINtec R 62 Eligard R 62 UPLYSO 62 tafamidis 62 Provectus Pharmaceuticals specializes 62 Genasense ® oblimersen 62 Nanoemulsion 62 Shigamabs R 62 Zelrix 62 MKC# MKC# PP 62 Aphthasol R 62 Metastatic Melanoma 62 Vimpat ® lacosamide 62 PEGylated Fab fragment 62 website http:/www.celsion.com 62 ATryn ® GTC recombinant 62 Inc. OTCBB ALRX 62 Camvia 62 Locteron exclusively 62 T Pred 62 Emezine 62 oxandrolone USP 62 Indaflex TM 62 sumatriptan DosePro 62 ZOSTAVAX 62 ChimeriVax JE 62 HFA MDI 62 non nucleoside inhibitor 62 PROGENSA R 62 Diamyd R 62 dihydrochloride Tablets 62 Novel Vaccine 62 mGluR5 negative 62 Preotact 62 Phase IIa Clinical Trial 62 topical non steroidal 62 OvaRex ® MAb 62 Ganciclovir 62 apricitabine ATC 62 Pivotal Phase II 62 TKM PLK1 62 XP# XP# 62 ocular formulation 62 rusalatide acetate 62 EPIX Pharmaceuticals 62 Investigational Compound 62 Sinobiomed Inc. 62 CONBRIZA 62 Antibody Drug Conjugate 62 M Enoxaparin 62 R#/MEM 62 ENTEREG ® 62 Commercialize Novel 62 Seasonal Influenza Vaccine 62 ACOMPLIA R 62 IND submission 62 Brentuximab Vedotin SGN 62 Eric Bjerkholt 62 Nasdaq PPHM 62 Acellular Pertussis Vaccine Adsorbed 62 Xenazine ® 62 Medicinal Products EMEA 62 Anthrax Vaccine Adsorbed 62 Luveris R Ovidrel R 62 Octreotide 62 Fast Track Designation 62 TransVax ™ 62 Inc. Nasdaq CYCC 62 Mg Usa 61 Ferumoxytol 61 Zenvia ™ 61 Prolongs Survival 61 Hematide ™ 61 NASDAQ BDSI 61 GA GCB 61 receptor tyrosine kinase inhibitor 61 oropharyngeal candidiasis OPC 61 Orapred ODT 61 using Crucell PER.C6 61 Noxafil 61 Microplasmin 61 Virulizin R 61 Monoclonal Antibody 61 personalized dendritic 61 muscarinic receptor agonists 61 MT# MEDI 61 AQ4N 61 Polysaccharide Diphtheria Toxoid Conjugate 61 visit smith.com 61 Ruconest 61 NYSE Amex HEB 61 palonosetron hydrochloride Injection Dacogen 61 CDP# 61 granulated mesalamine 61 Hexvix ® 61 Twinrix 61 Nexavar ® 61 Randomized Clinical Trials 61 Bicifadine 61 Ridaforolimus 61 DIFICID ™ 61 GRNVAC1 61 Mycograb 61 Teva Provides Update 61 includes TOLAMBA TM 61 candidate Gencaro TM 61 atacicept 61 Gets FDA Clearance 61 Omacetaxine 61 VitiGam TM 61 REMOXY ® 61 candidate epratuzumab 61 immunotherapeutic vaccine 61 Empatic ™ 61 KALBITOR ® 61 UltiMAb ® 61 arsenic trioxide injection 61 negative allosteric modulator 61 Respiratory Syncytial Virus RSV 61 candidate brentuximab vedotin 61 MelaFind R 61 Intermezzo ® zolpidem tartrate 61 NYSE Amex NBY clinical 61 LEVADEX ™ 61 diarrhea predominant irritable 61 PRNewswire FirstCall Peregrine Pharmaceuticals 61 Increlex TM 61 Atopic Dermatitis 61 PEGylated anti 61 BRILINTA 61 inhaled AAT 61 thrombin component 61 hepatitis C viral infection 61 R sipuleucel T 61 toenail onychomycosis 61 SparVax TM 61 ORENCIA ® 61 Neulasta R 61 XIAFLEX ® 61 Conjugate Vaccine 61 Hepatitis C HCV 61 Arno Therapeutics 61 Advancing Drugs 61 OLEPTRO 61 Inc. AMEX YMI 61 CYT# potent vascular disrupting 61 IV Busulfex 61 Aradigm Logo 61 PRNewswire FirstCall Indevus Pharmaceuticals 61 evaluating tivozanib 61 Prodarsan 61 Restoraderm R 61 MKC# 61 QuickVue R 61 Toddler Thin Strips Decongestant 61 Atripla combines 61 Sulonex TM 61 maribavir 61 NovaBay Pharmaceuticals Inc. 61 Mirapexin 61 Nasdaq SPPI 61 biodefense pathogens 61 OLpur TM H2H 61 XmAb ® 61 including thyroiditis RA 61 Quinamed 61 nasal powder 61 vaccine LAIV 61 Thelin TM 61 R#/MEM # 61 VEGFR2 inhibitor 61 Aloprim TM allopurinol sodium 61 YONDELIS R 61 Esbriet pirfenidone 61 Nanobody R 61 ImmuneRegen BioSciences Inc. 61 IG HCR ;) CO 61 glucokinase activator 61 Fortovase 61 BIM #A# 61 5 lipoxygenase inhibitor 61 nephropathic cystinosis 61 Inovocox TM 61 XAGRID 61 R MSCRAMM 61 ospemifene 61 Fungal Infections 61 Nasdaq OSCI 61 Lupus Drug 61 agonistic human 61 Pazopanib